idarubicin has been researched along with Blood Coagulation Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessandrino, EP; Avvisati, G; Bernasconi, C; Liso, V; Mandelli, F; Petti, MC; Piatti, C; Spadea, A; Specchia, G; Vegna, ML | 1 |
1 trial(s) available for idarubicin and Blood Coagulation Disorders
| Article | Year |
|---|---|
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Female; Follow-Up Studies; Humans; Idarubicin; Italy; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Multicenter Studies as Topic; Pilot Projects; Remission Induction | 1990 |